Ahmed Ali Al-Karmalawy (Ahmed A Al-Karmalawy)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 123

Top Venues

Journal of enzyme inhibition and medicinal chemistry

RSC advances

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

Horus University-Egypt, Faculty of Pharmacy

Al-Azhar University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Horus University-Egypt, Faculty of Pharmacy Sep 01 2018

Egypt

Lecturer, PhD :: Pharmaceutical Medicinal Chemistry

Education History

Al-Azhar University Sep 01 2014 - Nov 03 2017

Egypt

PHD :: Pharmaceutical Chemistry

Cairo University Faculty of Pharmacy

Egypt

BSC

Publications

Norhan M Eid, Ahmed Ali Al-Karmalawy, Taha M A Eldebss, Heba K A Elhakim
Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR-2 Inhibitors and Endowed with Apoptotic Potential. Chemistry & biodiversity (2024)
Marwa Abdel-Motaal, Dalal A Aldakhili, Ayman Abo Elmaaty, Marwa Sharaky, Mai A E Mourad, Abdullah Y A Alzahrani, Nadia A Mohamed, Ahmed Ali Al-Karmalawy
Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment. Drug development research 85 (4) (2024)
Fatma G Abdulrahman, Hamada S Abulkhair, Riham A Zidan, Asmaa I Alwakeel, Ahmed Ali Al-Karmalawy, Ebtehal M Husseiny
Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations. Future medicinal chemistry (2024)
Dalia S El-Gamil, Mohamed Y Zaky, Patrick M Maximous, Marwa Sharaky, Ahmed M El-Dessouki, Noura M Riad, Saad Shaaban, Mohammad Abdel-Halim, Ahmed Ali Al-Karmalawy
Exploring chromone-2-carboxamide derivatives for triple-negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights. Drug development research 85 (5) (2024)
Hager R Nofal, Ahmed Ali Al-Karmalawy, Ayman Abo Elmaaty, Mahmoud F Ismail, Ali Khalil Ali, Eslam M Abbass
Pharmacophore-based, rationale design, and efficient synthesis of novel tetrahydrobenzo[b]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators. Archiv der Pharmazie (2024)
Mohamed H Abd El-Razek, Ibrahim H Eissa, Ahmed Ali Al-Karmalawy, Ahmed A Elrashedy, Ahmed H El-Desoky, Mohamed Aboelmagd, Tarik A Mohamed, Mohamed-Elamir F Hegazy
epi -Magnolin, a tetrahydrofurofuranoid lignan from the oleo-gum resin of Commiphora wightii , as inhibitor of pancreatic cancer cell proliferation, in-vitro and in-silico study. Journal of biomolecular structure & dynamics (2024)
Hager R Nofal, Ahmed Ali Al-Karmalawy, Ayman Abo Elmaaty, Mahmoud F Ismail, Ali Khalil Ali, Eslam M Abbass
Pharmacophore-based, rationale design, and efficient synthesis of novel tetrahydrobenzo[b]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators. Archiv der Pharmazie 357 (9) (2024)
Norhan A Abdelrahman, Ahmed Ali Al-Karmalawy, Maiy Y Jaballah, Galal Yahya, Marwa Sharaky, Khaled A M Abouzid
Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy. RSC medicinal chemistry 15 (3) (2024)
Fatma G Abdulrahman, Hamada S Abulkhair, Riham A Zidan, Asmaa I Alwakeel, Ahmed Ali Al-Karmalawy, Ebtehal M Husseiny
Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations. Future medicinal chemistry 16 (2) (2024)
Marwa Abdel-Motaal, Dalal A Aldakhili, Ayman Abo Elmaaty, Marwa Sharaky, Mai A E Mourad, Abdullah Y A Alzahrani, Nadia A Mohamed, Ahmed Ali Al-Karmalawy
Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment. Drug development research 85 (4) (2024)
Norhan M Eid, Ahmed Ali Al-Karmalawy, Taha M A Eldebss, Heba K A Elhakim
Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR-2 Inhibitors and Endowed with Apoptotic Potential. Chemistry & biodiversity 21 (4) (2024)
Norhan A Abdelrahman, Ahmed Ali Al-Karmalawy, Maiy Y Jaballah, Galal Yahya, Marwa Sharaky, Khaled A M Abouzid
Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy. RSC medicinal chemistry 15 (3) (2024)
Samar A Antar, Nada A Ashour, Amir O Hamouda, Ayman M Noreddin, Ahmed Ali Al-Karmalawy
Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management. Inflammopharmacology (2024)
Marwa Abdel-Motaal, Dalal Ali Aldakhili, Ayman B Farag, Ayman Abo Elmaaty, Marwa Sharaky, Nadia A Mohamed, Saad Shaaban, Abdullah Yahya Abdullah Alzahrani, Ahmed Ali Al-Karmalawy
Design and synthesis of novel multi-target tetrabromophthalimides as CBS and Topo-II inhibitors and DNA intercalators. RSC medicinal chemistry (2024)
Fatma G Abdulrahman, Hamada S Abulkhair, Riham A Zidan, Asmaa I Alwakeel, Ahmed Ali Al-Karmalawy, Ebtehal M Husseiny
Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations. Future medicinal chemistry 16 (2) (2024)
Fatma G Abdulrahman, Hamada S Abulkhair, Riham A Zidan, Asmaa I Alwakeel, Ahmed Ali Al-Karmalawy, Ebtehal M Husseiny
Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations. Future medicinal chemistry 16 (2) (2024)
Saad Shaaban, Hanan A Althikrallah, Amr Negm, Ayman Abo Elmaaty, Ahmed Ali Al-Karmalawy
Repurposed organoselenium tethered amidic acids as apoptosis inducers in melanoma cancer via P53, BAX, caspases-3, 6, 8, 9, BCL-2, MMP2, and MMP9 modulations. RSC advances 14 (26) (2024)
Ashraf K El-Damasy, Hyun Ji Kim, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Mohamed M Khalifa, Eun-Kyoung Bang, Gyochang Keum
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Ashraf K El-Damasy, Hyun Ji Kim, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Mohamed M Khalifa, Eun-Kyoung Bang, Gyochang Keum
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Norhan M Eid, Ahmed Ali Al-Karmalawy, Taha M A Eldebss, Heba K A Elhakim
Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR-2 Inhibitors and Endowed with Apoptotic Potential. Chemistry & biodiversity 21 (4) (2024)
Saad Shaaban, Hanan A Althikrallah, Amr Negm, Ayman Abo Elmaaty, Ahmed Ali Al-Karmalawy
Repurposed organoselenium tethered amidic acids as apoptosis inducers in melanoma cancer via P53, BAX, caspases-3, 6, 8, 9, BCL-2, MMP2, and MMP9 modulations. RSC advances 14 (26) (2024)
Dalia S El-Gamil, Mohamed Y Zaky, Patrick M Maximous, Marwa Sharaky, Ahmed M El-Dessouki, Noura M Riad, Saad Shaaban, Mohammad Abdel-Halim, Ahmed Ali Al-Karmalawy
Exploring chromone-2-carboxamide derivatives for triple-negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights. Drug development research 85 (5) (2024)
Hwa Young Lee, Ahmed Elkamhawy, Ahmed Ali Al-Karmalawy, Hossam Nada, Simone Giovannuzzi, Claudiu T Supuran, Kyeong Lee
Chalcone-based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies. Archiv der Pharmazie (2024)
Arafa Musa, Saleh K Ihmaid, David L Hughes, Musa A Said, Hamada S Abulkhair, Ahmed H El-Ghorab, Mohamed Abdelwahab Abdelgawad, Khaled Shalaby, Mohamed E Shaker, Khalid Saad Alharbi, Nasser Hadal Alotaibi, Deborah L Kays, Laurence J Taylor, Della Grace Thomas Parambi, Sami I Alzarea, Ahmed Ali Al-Karmalawy, Hany E A Ahmed, Ahmed M El-Agrody
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro , and in silico mechanistic investigations. Journal of biomolecular structure & dynamics (2023)
Samia M Al-Muntaser, Ahmed Ali Al-Karmalawy, Abeer M El-Naggar, Ali Khalil Ali, Nour E A Abd El-Sattar, Eslam M Abbass
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies. RSC advances 13 (18) (2023)
Ahmed Ali Al-Karmalawy, Mai H A Mousa, Marwa Sharaky, Mai A E Mourad, Ahmed M El-Dessouki, Amir O Hamouda, Radwan Alnajjar, Abdelmoneim A Ayed, Moataz A Shaldam, Haytham O Tawfik
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments. Journal of medicinal chemistry 67 (1) (2023)
Yousra T Eloutify, Riham Adel El-Shiekh, Khaled Meselhy Ibrahim, Ahmad R Hamed, Ahmed Ali Al-Karmalawy, Aya A Shokry, Yasmine H Ahmed, Bharathi Avula, Kumar Katragunta, Ikhlas A Khan, Meselhy Ragab Meselhy
Bioactive fraction from Plumeria obtusa L. attenuates LPS-induced acute lung injury in mice and inflammation in RAW 264.7 macrophages: LC/QToF-MS and molecular docking. Inflammopharmacology (2023)
Samar A El-Kalyoubi, Samar S Elbaramawi, Ahmed G Eissa, Essam Al Ageeli, Yahya Hasan Hobani, Aya Ali El-Sharkawy, Hossam Taha Mohamed, Ahmed Ali Al-Karmalawy, Hamada S Abulkhair
Design and synthesis of novel uracil-linked Schiff bases as dual histone deacetylase type II/topoisomerase type I inhibitors with apoptotic potential. Future medicinal chemistry (2023)
Ahmed Ali Al-Karmalawy, Mai H A Mousa, Marwa Sharaky, Mai A E Mourad, Ahmed M El-Dessouki, Amir O Hamouda, Radwan Alnajjar, Abdelmoneim A Ayed, Moataz A Shaldam, Haytham O Tawfik
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments. Journal of medicinal chemistry (2023)
Ahmed Elkamhawy, Na Kyoung Oh, Noha A Gouda, Magda H Abdellattif, Saud O Alshammari, Mohammad A S Abourehab, Qamar A Alshammari, Amany Belal, Minkyoung Kim, Ahmed Ali Al-Karmalawy, Kyeong Lee
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations. Metabolites 13 (2) (2023)
Ahmed Ali Al-Karmalawy, Dalia S El-Gamil, Rabeh El-Shesheny, Marwa Sharaky, Radwan Alnajjar, Omnia Kutkat, Yassmin Moatasim, Mohamed Elagawany, Sara T Al-Rashood, Faizah A Binjubair, Wagdy M Eldehna, Ayman M Noreddin, Mohamed Y Zakaria
Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N -(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Samar El-Kalyoubi, Mohamed M Khalifa, Mahmoud T Abo-Elfadl, Ahmed A El-Sayed, Ahmed Elkamhawy, Kyeong Lee, Ahmed Ali Al-Karmalawy
Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Samia M Al-Muntaser, Ahmed Ali Al-Karmalawy, Abeer M El-Naggar, Ali Khalil Ali, Nour E A Abd El-Sattar, Eslam M Abbass
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies. RSC advances 13 (18) (2023)
Seohyun Son, Ahmed Elkamhawy, Anam Rana Gul, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Ahmed Abdeen, Samah F Ibrahim, Saud O Alshammari, Qamar A Alshammari, Won Jun Choi, Tae Jung Park, Kyeong Lee
Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Aya S Shalaby, Hanaa H Eid, Riham Adel El-Shiekh, Osama G Mohamed, Ashootosh Tripathi, Ahmed Ali Al-Karmalawy, Amany A Sleem, Fatma Adly Morsy, Khaled M Ibrahim, Soad H Tadros, Fadia S Youssef
Taming Food-Drug Interaction Risk: Potential Inhibitory Effects of Citrus Juices on Cytochrome Liver Enzymes Can Safeguard the Liver from Overdose Paracetamol-Induced Hepatotoxicity. ACS omega 8 (29) (2023)
Ahmed Elkamhawy, Na Kyoung Oh, Noha A Gouda, Magda H Abdellattif, Saud O Alshammari, Mohammad A S Abourehab, Qamar A Alshammari, Amany Belal, Minkyoung Kim, Ahmed Ali Al-Karmalawy, Kyeong Lee
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations. Metabolites 13 (2) (2023)
Samar A Antar, Nada A Ashour, Mohamed E Marawan, Ahmed Ali Al-Karmalawy
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. International journal of molecular sciences 24 (4) (2023)
Samar A Antar, Nada A Ashour, Mohamed E Marawan, Ahmed Ali Al-Karmalawy
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. International journal of molecular sciences 24 (4) (2023)
Ahmed M Kandeil, Mounir Abi-Said, Rebecca Badra, Rabeh El Shesheny, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Zumama Khalid, Mina Nabil Kamel, Walid Abi Habib, Jad Abdallah, Vijaykrishna Dhanasekaran, Richard John Webby, Ghazi Kayali
Detection of Coronaviruses in Bats in Lebanon during 2020. Pathogens (Basel, Switzerland) 12 (7) (2023)
Ahmed Elkamhawy, Na Kyoung Oh, Noha A Gouda, Magda H Abdellattif, Saud O Alshammari, Mohammad A S Abourehab, Qamar A Alshammari, Amany Belal, Minkyoung Kim, Ahmed Ali Al-Karmalawy, Kyeong Lee
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations. Metabolites 13 (2) (2023)
Ahmed Ali Al-Karmalawy, Dalia S El-Gamil, Rabeh El-Shesheny, Marwa Sharaky, Radwan Alnajjar, Omnia Kutkat, Yassmin Moatasim, Mohamed Elagawany, Sara T Al-Rashood, Faizah A Binjubair, Wagdy M Eldehna, Ayman M Noreddin, Mohamed Y Zakaria
Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N -(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Ahmed I Abd El Maksoud, Ahmed Ali Al-Karmalawy, Dalia ElEbeedy, Aml Ghanem, Yasmin Rasheed, Ibrahim A Ibrahim, Reem A Elghaish, Amany Belal, Mona A Raslan, Rehab F Taher
Symbiotic Antidiabetic Effect of Lactobacillus casei and the Bioactive Extract of Cleome droserifolia (Forssk.) Del. on Mice with Type 2 Diabetes Induced by Alloxan. Chemistry & biodiversity (2023)
Ahmed Mowafy Tafish, Mohamed El Sherbiny, Ahmed Ali Al-Karmalawy, Osama Abd El-Azeem Soliman, Noha Mohamed Saleh
Carvacrol-Loaded Phytosomes for Enhanced Wound Healing: Molecular Docking, Formulation, DoE-Aided Optimization, and in vitro/in vivo Evaluation. International journal of nanomedicine 18 (2023)
Ahmed Ali Al-Karmalawy, Dalia S El-Gamil, Rabeh El-Shesheny, Marwa Sharaky, Radwan Alnajjar, Omnia Kutkat, Yassmin Moatasim, Mohamed Elagawany, Sara T Al-Rashood, Faizah A Binjubair, Wagdy M Eldehna, Ayman M Noreddin, Mohamed Y Zakaria
Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N -(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Ahmed Ali Al-Karmalawy, Dalia S El-Gamil, Rabeh El-Shesheny, Marwa Sharaky, Radwan Alnajjar, Omnia Kutkat, Yassmin Moatasim, Mohamed Elagawany, Sara T Al-Rashood, Faizah A Binjubair, Wagdy M Eldehna, Ayman M Noreddin, Mohamed Y Zakaria
Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N -(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mai A E Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A E Mourad, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Ahmed Elkamhawy, Eun Joo Roh, Ahmed Ali Al-Karmalawy
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Faten Farouk, Ayman Abo Elmaaty, Ahmed Elkamhawy, Haytham O Tawfik, Radwan Alnajjar, Mohammed A S Abourehab, Mohamed A Saleh, Wagdy M Eldehna, Ahmed Ali Al-Karmalawy
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro , molecular docking, molecular dynamics, and SAR studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Ahmed A Hamed, Osama G Mohamed, Elsayed A Aboutabl, Fify I Fathy, Ghada A Fawzy, Riham Adel El-Shiekh, Ahmed Ali Al-Karmalawy, Areej M Al-Taweel, Ashootosh Tripathi, Tarek R Elsayed
Identification of Antimicrobial Metabolites from the Egyptian Soil-Derived Amycolatopsis keratiniphila Revealed by Untargeted Metabolomics and Molecular Docking. Metabolites 13 (5) (2023)
Mohammed Farrag El-Behairy, Walaa Hamada Abd-Allah, Mohamed M Khalifa, Mohamed S Nafie, Mohamed A Saleh, Mohammed S Abdel-Maksoud, Tarfah Al-Warhi, Wagdy M Eldehna, Ahmed Ali Al-Karmalawy
Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Seohyun Son, Ahmed Elkamhawy, Anam Rana Gul, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Ahmed Abdeen, Samah F Ibrahim, Saud O Alshammari, Qamar A Alshammari, Won Jun Choi, Tae Jung Park, Kyeong Lee
Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Ahmed A Hamed, Riham Adel El-Shiekh, Osama G Mohamed, Elsayed A Aboutabl, Fify I Fathy, Ghada A Fawzy, Areej M Al-Taweel, Tarek R Elsayed, Ashootosh Tripathi, Ahmed Ali Al-Karmalawy
Cholinesterase Inhibitors from an Endophytic Fungus Aspergillus niveus Fv-er401: Metabolomics, Isolation and Molecular Docking. Molecules (Basel, Switzerland) 28 (6) (2023)
Ahmed A Hamed, Riham Adel El-Shiekh, Osama G Mohamed, Elsayed A Aboutabl, Fify I Fathy, Ghada A Fawzy, Areej M Al-Taweel, Tarek R Elsayed, Ashootosh Tripathi, Ahmed Ali Al-Karmalawy
Cholinesterase Inhibitors from an Endophytic Fungus Aspergillus niveus Fv-er401: Metabolomics, Isolation and Molecular Docking. Molecules (Basel, Switzerland) 28 (6) (2023)
Samar A Antar, Nada A Ashour, Mohamed E Marawan, Ahmed Ali Al-Karmalawy
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. International journal of molecular sciences 24 (4) (2023)
Maan T Khayat, Hany E A Ahmed, Abdelsattar Mansour Omar Ebeid, Yosra A Muhammad, Khadijah A Mohammad, Azizah M Malebari, Ahdab N Khayyat, Ahmed H Halawa, Hamada S Abulkhair, Ahmed Ali Al-Karmalawy, Mohammed Almaghrabi, Majed Alharbi, Anfal S Aljahdali, Ahmed M El-Agrody
A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses. Journal of biomolecular structure & dynamics (2023)
Mai A E Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A E Mourad, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Ahmed Elkamhawy, Eun Joo Roh, Ahmed Ali Al-Karmalawy
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mai A E Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A E Mourad, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Ahmed Elkamhawy, Eun Joo Roh, Ahmed Ali Al-Karmalawy
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Seohyun Son, Ahmed Elkamhawy, Anam Rana Gul, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Ahmed Abdeen, Samah F Ibrahim, Saud O Alshammari, Qamar A Alshammari, Won Jun Choi, Tae Jung Park, Kyeong Lee
Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mai A E Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A E Mourad, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Ahmed Elkamhawy, Eun Joo Roh, Ahmed Ali Al-Karmalawy
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Ahmed Ali Al-Karmalawy, Mai H A Mousa, Marwa Sharaky, Mai A E Mourad, Ahmed M El-Dessouki, Amir O Hamouda, Radwan Alnajjar, Abdelmoneim A Ayed, Moataz A Shaldam, Haytham O Tawfik
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments. Journal of medicinal chemistry 67 (1) (2023)
Ahmed Ali Al-Karmalawy, Mai H A Mousa, Marwa Sharaky, Mai A E Mourad, Ahmed M El-Dessouki, Amir O Hamouda, Radwan Alnajjar, Abdelmoneim A Ayed, Moataz A Shaldam, Haytham O Tawfik
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments. Journal of medicinal chemistry 67 (1) (2023)
Samar A Antar, Nada A Ashour, Mohamed E Marawan, Ahmed Ali Al-Karmalawy
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. International journal of molecular sciences 24 (4) (2023)
Samar A Antar, Nada A Ashour, Mohamed E Marawan, Ahmed Ali Al-Karmalawy
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. International journal of molecular sciences 24 (4) (2023)
Ahmed Ali Al-Karmalawy, Dalia S El-Gamil, Rabeh El-Shesheny, Marwa Sharaky, Radwan Alnajjar, Omnia Kutkat, Yassmin Moatasim, Mohamed Elagawany, Sara T Al-Rashood, Faizah A Binjubair, Wagdy M Eldehna, Ayman M Noreddin, Mohamed Y Zakaria
Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N -(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Ayman Abo Elmaaty, Faizah A Binjubair, Sara T Al-Rashood, Basma S Mansour, Ahmed Elkamhawy, Wagdy M Eldehna, Khaled Ahmed Mansour
Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from Jasminum humile ; in silico and in virto assessments with structure-activity relationship. Journal of biomolecular structure & dynamics (2023)
Samia M Al-Muntaser, Ahmed Ali Al-Karmalawy, Abeer M El-Naggar, Ali Khalil Ali, Nour E A Abd El-Sattar, Eslam M Abbass
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies. RSC advances 13 (18) (2023)
Mohammed Farrag El-Behairy, Walaa Hamada Abd-Allah, Mohamed M Khalifa, Mohamed S Nafie, Mohamed A Saleh, Mohammed S Abdel-Maksoud, Tarfah Al-Warhi, Wagdy M Eldehna, Ahmed Ali Al-Karmalawy
Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Samia M Al-Muntaser, Ahmed Ali Al-Karmalawy, Abeer M El-Naggar, Ali Khalil Ali, Nour E A Abd El-Sattar, Eslam M Abbass
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies. RSC advances 13 (18) (2023)
Seohyun Son, Ahmed Elkamhawy, Anam Rana Gul, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Ahmed Abdeen, Samah F Ibrahim, Saud O Alshammari, Qamar A Alshammari, Won Jun Choi, Tae Jung Park, Kyeong Lee
Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Ahmed A Hamed, Riham Adel El-Shiekh, Osama G Mohamed, Elsayed A Aboutabl, Fify I Fathy, Ghada A Fawzy, Areej M Al-Taweel, Tarek R Elsayed, Ashootosh Tripathi, Ahmed Ali Al-Karmalawy
Cholinesterase Inhibitors from an Endophytic Fungus Aspergillus niveus Fv-er401: Metabolomics, Isolation and Molecular Docking. Molecules (Basel, Switzerland) 28 (6) (2023)
Ahmed Elkamhawy, Na Kyoung Oh, Noha A Gouda, Magda H Abdellattif, Saud O Alshammari, Mohammad A S Abourehab, Qamar A Alshammari, Amany Belal, Minkyoung Kim, Ahmed Ali Al-Karmalawy, Kyeong Lee
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations. Metabolites 13 (2) (2023)
Ahmed A Gaber, Marwa Sharaky, Ayman Abo Elmaaty, Mohamed M Hammouda, Ahmed Ae Mourad, Samy Y Elkhawaga, Mahmoud Mohamed Mokhtar, Amr S Abouzied, Mai Ae Mourad, Ahmed Ali Al-Karmalawy
Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducers. Future medicinal chemistry (2023)
Howaida I Abd-Alla, Omnia Kutkat, Heba-Tollah M Sweelam, Wagdy M Eldehna, Marwa A Mostafa, Magda T Ibrahim, Yassmin Moatasim, Mohamed GabAllah, Ahmed Ali Al-Karmalawy
Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies. Metabolites 12 (11) (2022)
Wael H Roshdy, Ahmed M Kandeil, Rabeh El Shesheny, Mohamed K Khalifa, Ahmed Ali Al-Karmalawy, Shymaa Showky, Amel Naguib, Nancy Elguindy, Manal Fahim, Hanaa Abu Elsood, Ahmed El Taweel, Azza Salamony, Amira Mohsen, Ghazi Kayali, Mohamed Ahmed Ali, Amr Kandeel
Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021. Pathogens (Basel, Switzerland) 11 (8) (2022)
Tarfah Al-Warhi, Ahmed Ali Al-Karmalawy, Ayman Abo Elmaaty, Maha A Alshubramy, Marwa Abdel-Motaal, Taghreed A Majrashi, Medhat Asem, Ahmed Nabil, Wagdy M Eldehna, Marwa Sharaky
Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2022)
Mohamed A Salem, Nora M Aborehab, Ahmed Ali Al-Karmalawy, Alisdair R Fernie, Saleh Alseekh, Shahira M Ezzat
Potential Valorization of Edible Nuts By-Products: Exploring the Immune-Modulatory and Antioxidants Effects of Selected Nut Shells Extracts in Relation to Their Metabolic Profiles. Antioxidants (Basel, Switzerland) 11 (3) (2022)
Sanaa A Ahmed, Moumen S Kamel, Moustafa O Aboelez, Xiang Ma, Ahmed Ali Al-Karmalawy, Sayed A S Mousa, Elders Kh Shokr, H Abdel-Ghany, Amany Belal, Mohamed A El Hamd, Zafer S Al Shehri, Mahmoud Abd El Aleem Ali Ali El-Remaily
Thieno[2,3- b ]thiophene Derivatives as Potential EGFR WT and EGFRT 790M Inhibitors with Antioxidant Activities: Microwave-Assisted Synthesis and Quantitative In Vitro and In Silico Studies. ACS omega 7 (49) (2022)
Sanaa A Ahmed, Moumen S Kamel, Moustafa O Aboelez, Xiang Ma, Ahmed Ali Al-Karmalawy, Sayed A S Mousa, Elders Kh Shokr, H Abdel-Ghany, Amany Belal, Mohamed A El Hamd, Zafer S Al Shehri, Mahmoud Abd El Aleem Ali Ali El-Remaily
Thieno[2,3- b ]thiophene Derivatives as Potential EGFR WT and EGFRT 790M Inhibitors with Antioxidant Activities: Microwave-Assisted Synthesis and Quantitative In Vitro and In Silico Studies. ACS omega 7 (49) (2022)
Ahmed Ali Al-Karmalawy, Mohamed S Nafie, Moataz A Shaldam, Ayman Abo Elmaaty, Samar A Antar, Anwar A El-Hamaky, Mohamed A Saleh, Ahmed Elkamhawy, Haytham O Tawfik
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. Journal of medicinal chemistry 66 (1) (2022)
Tarfah Al-Warhi, Mostafa M Elbadawi, Alessandro Bonardi, Alessio Nocentini, Ahmed Ali Al-Karmalawy, Nada Aljaeed, Ohoud J Alotaibi, Hatem A Abdel-Aziz, Claudiu T Supuran, Wagdy M Eldehna
Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Mai E Hussein, Osama G Mohamed, Ahlam M El-Fishawy, Hesham I El-Askary, Ahmed A Hamed, Marwa M Abdel-Aziz, Radwan Alnajjar, Amany Belal, Ahmed M Naglah, Abdulrahman A Al-Mehizia, Ahmed Ali Al-Karmalawy, Ashootosh Tripathi, Amira S El Senousy
Anticholinesterase Activity of Budmunchiamine Alkaloids Revealed by Comparative Chemical Profiling of Two Albizia spp., Molecular Docking and Dynamic Studies. Plants (Basel, Switzerland) 11 (23) (2022)
Mai E Hussein, Osama G Mohamed, Ahlam M El-Fishawy, Hesham I El-Askary, Ahmed A Hamed, Marwa M Abdel-Aziz, Radwan Alnajjar, Amany Belal, Ahmed M Naglah, Abdulrahman A Al-Mehizia, Ahmed Ali Al-Karmalawy, Ashootosh Tripathi, Amira S El Senousy
Anticholinesterase Activity of Budmunchiamine Alkaloids Revealed by Comparative Chemical Profiling of Two Albizia spp., Molecular Docking and Dynamic Studies. Plants (Basel, Switzerland) 11 (23) (2022)
Khaled Ahmed Mansour, Ahmed Elbermawi, Ahmed Ali Al-Karmalawy, Mohamed-Farid Lahloub, Mona El-Neketi
Cytotoxic effects of extracts obtained from plants of the Oleaceae family: bio-guided isolation and molecular docking of new secoiridoids from Jasminum humile . Pharmaceutical biology 60 (1) (2022)
Ahmed A Gaber, Mohamed Sobhy, Abdallah Turky, Hanan Gaber Abdulwahab, Ahmed Ali Al-Karmalawy, Mostafa A Elhendawy, Mohamed M Radwan, Eslam B Elkaeed, Ibrahim M Ibrahim, Heba S A Elzahabi, Ibrahim H Eissa
Discovery of new 1 H -pyrazolo[3,4- d ]pyrimidine derivatives as anticancer agents targeting EGFR WT and EGFR T790M . Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Amany Belal, Mohamed A Elanany, Eman Y Santali, Ahmed Ali Al-Karmalawy, Moustafa O Aboelez, Ali H Amin, Magda H Abdellatif, Ahmed B M Mehany, Hazem Elkady
Screening a Panel of Topical Ophthalmic Medications against MMP-2 and MMP-9 to Investigate Their Potential in Keratoconus Management. Molecules (Basel, Switzerland) 27 (11) (2022)
Wael H Roshdy, Mohamed K Khalifa, James Emmanuel San, Houriiyah Tegally, Eduan Wilkinson, Shymaa Showky, Darren Patrick Martin, Monika Moir, Amel Naguib, Nancy Elguindy, Mokhtar R Gomaa, Manal Fahim, Hanaa Abu Elsood, Amira Mohsen, Ramy Galal, Mohamed Hassany, Richard J Lessells, Ahmed Ali Al-Karmalawy, Rabeh El Shesheny, Ahmed M Kandeil, Mohamed Ahmed Ali, Tulio de Oliveira
SARS-CoV-2 Genetic Diversity and Lineage Dynamics in Egypt during the First 18 Months of the Pandemic. Viruses 14 (9) (2022)
Ahmed Ali Al-Karmalawy, Mohamed S Nafie, Moataz A Shaldam, Ayman Abo Elmaaty, Samar A Antar, Anwar A El-Hamaky, Mohamed A Saleh, Ahmed Elkamhawy, Haytham O Tawfik
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. Journal of medicinal chemistry (2022)
Amany Belal, Nagwa M Abdel Gawad, Ahmed B M Mehany, Mohammed A S Abourehab, Hazem Elkady, Ahmed Ali Al-Karmalawy, Ahmed S Ismael
Design, synthesis and molecular docking of new fused 1 H -pyrroles, pyrrolo[3,2- d ]pyrimidines and pyrrolo[3,2- e ][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Sahar M El-Haggar, Sahar K Hegazy, Sherief M Abd-Elsalam, Eslam B Elkaeed, Ahmed Ali Al-Karmalawy, Mostafa M Bahaa
A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of inflammation research 15 (2022)
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, Noura M Abo Shama, Eman Y Santali, Bahaa Elgendy, Ahmed Ali Al-Karmalawy
Ligand-based design, synthesis, computational insights, and in vitro studies of novel N -(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Ateyatallah Aljuhani, Hany E A Ahmed, Saleh K Ihmaid, Abdelsattar M Omar, Sultan S Althagfan, Yaser M Alahmadi, Iqrar Ahmad, Harun Patel, Sahar Ahmed, Mohannad A Almikhlafi, Ahmed M El-Agrody, Mohamed F Zayed, Safaa Abdulrahman Turkistani, Shorouk H Abulkhair, Mohammed Almaghrabi, Samir A Salama, Ahmed Ali Al-Karmalawy, Hamada S Abulkhair
In vitro and computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-M Pro inhibitors. RSC advances 12 (41) (2022)
Mahmoud M A Elsayed, Moustafa O Aboelez, Mohamed S Mohamed, Reda A Mahmoud, Ahmed A El-Shenawy, Essam A Mahmoud, Ahmed Ali Al-Karmalawy, Eman Y Santali, Sameer Alshehri, Mahmoud Elkot Mostafa Elsadek, Mohamed A El Hamd, Abd El Hakim Ramadan
Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study. Pharmaceutics 14 (8) (2022)
Mohamed M Hammoud, Muhammad Khattab, Marwa Abdel-Motaal, Johan Van der Eycken, Radwan Alnajjar, Hamada S Abulkhair, Ahmed Ali Al-Karmalawy
Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity. Journal of biomolecular structure & dynamics (2022)
Nada A Ashour, Ayman Abo Elmaaty, Amany A Sarhan, Eslam B Elkaeed, Ahmed M Moussa, Ibrahim Ali Erfan, Ahmed Ali Al-Karmalawy
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval. Drug design, development and therapy 16 (2022)
Mai E Hussein, Osama G Mohamed, Ahlam M El-Fishawy, Hesham I El-Askary, Ahmed A Hamed, Marwa M Abdel-Aziz, Radwan Alnajjar, Amany Belal, Ahmed M Naglah, Abdulrahman A Al-Mehizia, Ahmed Ali Al-Karmalawy, Ashootosh Tripathi, Amira S El Senousy
Anticholinesterase Activity of Budmunchiamine Alkaloids Revealed by Comparative Chemical Profiling of Two Albizia spp., Molecular Docking and Dynamic Studies. Plants (Basel, Switzerland) 11 (23) (2022)
Ahmed Elkamhawy, Seohyun Son, Hwa Young Lee, Mahmoud Hamed Elmaghrabey, Mohamed A El Hamd, Saud O Alshammari, Abeer A Abdelhameed, Qamar A Alshammari, Ahmed Abdeen, Samah F Ibrahim, Wael A Mahdi, Sultan M Alshehri, Radwan Alnajjar, Won Jun Choi, Ahmed Ali Al-Karmalawy, Kyeong Lee
Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Ahmed Ali Al-Karmalawy, Mohamed S Nafie, Moataz A Shaldam, Ayman Abo Elmaaty, Samar A Antar, Anwar A El-Hamaky, Mohamed A Saleh, Ahmed Elkamhawy, Haytham O Tawfik
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. Journal of medicinal chemistry 66 (1) (2022)
Tarfah Al-Warhi, Diaaeldin M Elimam, Zainab M Elsayed, Marwa M Abdel-Aziz, Raed M Maklad, Ahmed Ali Al-Karmalawy, Kamyar Afarinkia, Mohammed A S Abourehab, Hatem A Abdel-Aziz, Wagdy M Eldehna
Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens. RSC advances 12 (48) (2022)
Amany Belal, Hazem Elkady, Ahmed Ali Al-Karmalawy, Ali H Amin, Mohammed M Ghoneim, Mohamed El Sherbiny, Rasha Hamed Al-Serwi, Mohamed Attia Abdou, Mona H Ibrahim, Ahmed B M Mehany
Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations. Molecules (Basel, Switzerland) 27 (17) (2022)
Ahmed Elkamhawy, Seohyun Son, Hwa Young Lee, Mahmoud Hamed Elmaghrabey, Mohamed A El Hamd, Saud O Alshammari, Abeer A Abdelhameed, Qamar A Alshammari, Ahmed Abdeen, Samah F Ibrahim, Wael A Mahdi, Sultan M Alshehri, Radwan Alnajjar, Won Jun Choi, Ahmed Ali Al-Karmalawy, Kyeong Lee
Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Ayman Abo Elmaaty, Wagdy M Eldehna, Muhammad Khattab, Omnia Kutkat, Radwan Alnajjar, Ahmed N El-Taweel, Sara T Al-Rashood, Mohammad A S Abourehab, Faizah A Binjubair, Mohamed A Saleh, Amany Belal, Ahmed Ali Al-Karmalawy
Anticoagulants as Potential SARS-CoV-2 M pro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies. International journal of molecular sciences 23 (20) (2022)

Ahmed Ali Al-Karmalawy.css-eqlu8i{font-size:small;padding-left:4px;} (Ahmed A Al-Karmalawy)

Publication Activity (10 Years)

Top Topics

Top Venues

Ahmed Ali Al-Karmalawy (Ahmed A Al-Karmalawy)